HOME >> MEDICINE >> NEWS
Drug combination shows potent punch against HIV in children

Philadelphia, Pa. - A study headed by a physician at The Children's Hospital of Philadelphia has shown that a novel combination of drugs achieves strong, sustained results in controlling HIV infection in children, according to an article in the December 16 New England Journal of Medicine. Forty-eight weeks after the treatment began, the virus, which causes AIDS, remained at undetectable levels in more than half the children studied. "These impressive results expand our treatment options for HIV-infected children," said Stuart E. Starr, M.D., chief of Immunologic and Infectious Diseases at The Children's Hospital of Philadelphia, the lead author and chair of the multicenter study. The fact that one of the drugs, efavirenz, is taken only once a day is a step toward simplifying the complicated, often difficult treatment regimen for children with HIV.

One novel feature of the trial was that levels of efavirenz and another drug, nelfinavir, were measured in each child's bloodstream during the course of the study, and subsequent doses were individually adjusted to aim for better results in fighting the virus. Often in clinical trials, drug doses are standardized and remain the same throughout the study period.

The study was conducted in 57 HIV-infected children age 3 to 16 at 18 sites participating in the Pediatric AIDS Clinical Trial Group. The children received a combination of the drugs efavirenz, nelfinavir and one or more drugs called nucleoside reverse transcriptase inhibitors (NRTIs). Nearly all of the children had earlier been treated with NRTIs, a class of drugs that includes AZT and ddI. The virus was considered to be at undetectable levels if tests that detect as few as 50 copies of virus particles in each milliliter of blood were negative. Before the study, the children had more than 400 particles per milliliter, enough to cause signs such as failure to thrive and an enlarged liver. Children with undetectable HIV levels,
'"/>

Contact: Maria Stearns
stearnsm@email.chop.edu
215-590-4091
Children's Hospital of Philadelphia
14-Dec-1999


Page: 1 2

Related medicine news :

1. Three anti-platelet drugs used in combination are safe
2. No advantage of combination drug therapy for chronic hepatitis B Infection
3. Certain high blood pressure combination therapies elevate risk for death from cardiovascular disease
4. Ugandan study highlights best drug combinations for treating malaria in Africa
5. Drug combination shows promise in treating hepatitis C
6. Study shows weight-based REBETOL dosing in combination with PEG-INTRON significantly improves ...
7. Therapy, medication combination superior for children with obsessive-compulsive disorder
8. Yerkes researchers discover combination of drug therapies reduces cocaine use in primates
9. Diabetes drug improves metabolic changes associated with HIV combination therapy
10. Study finds combination therapy successful for treating depression
11. Baby and coated aspirin equally effective in thinning of blood when taken in combination with Plavix

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... ... January 10, 2020 , ... WellHaven Pet Health, a ... in a new online community coming in February 2020, LEAD WELL with WOMEN. The ... Wellbeing Village. , The vision of LEAD WELL with WOMEN is to empower women, ...
(Date:1/10/2020)... ... January 10, 2020 , ... SMG3Rx, a clinical ... be attending the HIMSS (Healthcare Information and Management Systems Society) Global Conference & ... health information and technology event of the year, where professionals throughout the global ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... sciences teams, announced today that the company is rebranding as Red Nucleus R&D, ... and performance solutions for the life sciences industry. , The addition of ...
(Date:1/8/2020)... ... January 09, 2020 , ... Real ... Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata ... (RWD) to generate evidence and identify gaps and challenges when conducting trials? The ...
(Date:1/7/2020)... ... January 07, 2020 , ... G-CON Manufacturing, ... to the company’s 200,000 sq. ft. manufacturing site in College Station, TX. The ... dedicated to POD architectural, mechanical, electrical and automation fit out. , “This facility ...
Breaking Medicine News(10 mins):
(Date:1/8/2020)... Mich. (PRWEB) , ... January 08, 2020 , ... ... leader in FDA compliance consulting, is proud to announce the attainment of a ... Council, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC). ...
(Date:1/8/2020)... ... January 09, 2020 , ... ... partner practices a complimentary freezer program. The cryogenic freezer allows practices to have ... top stem cell and exosome biologics require cryogenic freezing. This may include a ...
(Date:1/7/2020)... ... 2020 , ... Myant Inc., the pioneers in Textile Computing™, will be showcasing ... CES 2020 (January 7-10, Las Vegas), including apparel from the Skiin Connected Health & ... of the CES 2020 Innovation Awards. , While electrocardiography, or the study of the ...
Breaking Medicine Technology:
Cached News: